Stay updated on CAN04 Combined with FOLFIRINOX in Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the CAN04 Combined with FOLFIRINOX in Pancreatic Cancer Clinical Trial page.

Latest updates to the CAN04 Combined with FOLFIRINOX in Pancreatic Cancer Clinical Trial page
- ChecktodayChange DetectedA site-wide NIH banner announces a transition from the term “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.SummaryDifference1%

- Check7 days agoChange DetectedThe footer site revision changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check14 days agoChange DetectedThe ClinicalTrials.gov footer revision changed from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check35 days agoChange DetectedThe study record page now displays a 403 Forbidden error, replacing the usual study details with an access-denied message. This indicates that the record cannot be viewed at the moment, affecting users' ability to access study information.SummaryDifference18%

- Check56 days agoChange DetectedThe page now shows Revision: v3.6.6, replacing the previous v3.6.5. This appears to be a minor metadata update rather than a change to study content.SummaryDifference0.1%

- Check78 days agoChange DetectedThe page revision has been updated from v3.6.4 to v3.6.5, reflecting a minor update to the site's underlying system. This update does not alter visible study information or functionality.SummaryDifference0.1%

Stay in the know with updates to CAN04 Combined with FOLFIRINOX in Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CAN04 Combined with FOLFIRINOX in Pancreatic Cancer Clinical Trial page.